MiniMed Group Common Stock Target Price

Analysts' average 12-month price target for MiniMed Group Common Stock is $25.

Get informed when a big investor buys or sells

+ Follow

Share Price

$23.29

Average Target Price

$25.10

7.8% upside

10 analysts in the last 4 months

High: $28 | Low: $16

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-09-02	Deutsche Bank	$25	7.4% upside
2026-09-02	Evercore ISIDaniel Markowitz	$27	16% upside
2026-09-02	UBS	$28	20.2% upside
2026-09-02	Mizuho Securities	$26	11.7% upside
2026-09-02	Wells Fargo	$28	20.2% upside
2026-09-01	Wells FargoLarry Biegelsen	$26	11.7% upside
2026-09-01	BTIGMarie Thibault	$28	20.2% upside
2026-07-28	UBS	$25	7.4% upside
2026-06-04	Piper SandlerMatt O'Brien	$16	31.3% downside
2026-06-04	Wells FargoLarry Biegelsen	$22	5.5% downside

MiniMed Group Common Stock (MMED) FAQ

The latest target price for MMED is $25. Investors often review this figure alongside MiniMed Group Common Stock's historical trend and sector peers before judging valuation or financial health.

MiniMed Group Common Stock trades near $23.29 while the consensus target sits at $25 (7.8% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting MMED's target price ($25), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.